| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |